董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| John Mastrototaro | 男 | Chief Executive Officer and Director | 64 | 64.63万美元 | 未持股 | 2025-09-26 |
| Rubén Caballero | 男 | Director | 56 | 5.98万美元 | 未持股 | 2025-09-26 |
| Brian Cullinan | 男 | Director | 65 | 8.98万美元 | 未持股 | 2025-09-26 |
| Emily T. Fairbairn | 女 | Director and Chair of the Board | 63 | 8.73万美元 | 未持股 | 2025-09-26 |
| Emily Wang Fairbairn | 女 | Director and Chair of the Board | 63 | 未披露 | 未持股 | 2025-09-26 |
| Shaheen Wirk | 男 | Director | 48 | 未披露 | 未持股 | 2025-09-26 |
| Michael Leabman | 男 | Chief Technology Officer and Director | 51 | 61.64万美元 | 未持股 | 2025-09-26 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| John Mastrototaro | 男 | Chief Executive Officer and Director | 64 | 64.63万美元 | 未持股 | 2025-09-26 |
| Jeremy Cogan | 男 | Chief Financial Officer | 56 | 38.56万美元 | 未持股 | 2025-09-26 |
| Michael Leabman | 男 | Chief Technology Officer and Director | 51 | 61.64万美元 | 未持股 | 2025-09-26 |
董事简历
中英对照 | 中文 | 英文- John Mastrototaro
-
John Mastrototaro自2020年12月起担任公司董事，并同意不迟于2021年4月1日成为我们的总裁兼首席执行官。Mastrototaro先生在医疗器械行业拥有超过30年的经验，领导创新并将新产品推向市场。Mastrototaro先生自2017年以来一直担任Orthosensor，Inc.的首席运营官。此前，Mastrototaro先生在Medtronic，plc.和Minimed，Inc.度过了职业生涯的大部分时间，在那里他在发起和领导糖尿病世界的一系列第一方面发挥了重要作用，包括动态连续血糖监测系统，该传感器增强了胰岛素泵和早期人工胰腺。在加入Orthosensor之前，Mastrototaro先生于2013年至2017年担任美敦力（Medtronic&8217；）的首位信息学副总裁，他在该职位上帮助制定了一项利用数据和分析改善梦百合交付的企业战略。在Medtronic&8217；s Diabetes Division任职期间，Mastrototaro先生担任多个职位，包括CTO，研发与业务发展副总裁和临床研究与健康事务全球副总裁。Mastrototaro先生的职业生涯始于礼来公司（Eli Lilly）。他持有Holy Cross College的数学和物理学士学位，以及Duke University的生物医学工程硕士和博士学位。Mastrototaro先生撰写了超过50篇同行评议的手稿，并拥有超过60项美国专利。
John Mastrototaro,has served as a director of the Company since December 2020 and as President and CEO since April 2021. Mr. Mastrototaro has over 30 years of experience in the medical device industry, leading innovation and bringing new products to the market. Mr. Mastrototaro served as the Chief Operating Officer of Orthosensor, Inc. from 2017 to March 2021. Previously, Mr. Mastrototaro spent the majority of his career with Medtronic, PLC. and MiniMed, Inc., where he was instrumental in initiating and leading a series of firsts in the world of diabetes, including the ambulatory continuous glucose monitoring system, the sensor augmented insulin pump and the early generations of the artificial pancreas. Prior to joining Orthosensor, Mr. Mastrototaro was Medtronic's first VP of Informatics from 2013 to 2017, a role in which he helped develop a corporate strategy for the Movano Inc. e of data and analytics to improve healthcare delivery. During his tenure in Medtronic's Diabetes division, Mr. Mastrototaro held a number of positions, including CTO, VP of R&D and Business Development and Global VP of Clinical Research and Health Affairs. Mr. Mastrototaro started his career with Eli Lilly. He holds a B.A. in Mathematics and Physics from Holy Cross College and M.S. and Ph.D. in Biomedical Engineering from Duke University. Mr. Mastrototaro has authored over 50 peer reviewed manuscripts and holds over 60 US patents. - John Mastrototaro自2020年12月起担任公司董事，并同意不迟于2021年4月1日成为我们的总裁兼首席执行官。Mastrototaro先生在医疗器械行业拥有超过30年的经验，领导创新并将新产品推向市场。Mastrototaro先生自2017年以来一直担任Orthosensor，Inc.的首席运营官。此前，Mastrototaro先生在Medtronic，plc.和Minimed，Inc.度过了职业生涯的大部分时间，在那里他在发起和领导糖尿病世界的一系列第一方面发挥了重要作用，包括动态连续血糖监测系统，该传感器增强了胰岛素泵和早期人工胰腺。在加入Orthosensor之前，Mastrototaro先生于2013年至2017年担任美敦力（Medtronic&8217；）的首位信息学副总裁，他在该职位上帮助制定了一项利用数据和分析改善梦百合交付的企业战略。在Medtronic&8217；s Diabetes Division任职期间，Mastrototaro先生担任多个职位，包括CTO，研发与业务发展副总裁和临床研究与健康事务全球副总裁。Mastrototaro先生的职业生涯始于礼来公司（Eli Lilly）。他持有Holy Cross College的数学和物理学士学位，以及Duke University的生物医学工程硕士和博士学位。Mastrototaro先生撰写了超过50篇同行评议的手稿，并拥有超过60项美国专利。
- John Mastrototaro,has served as a director of the Company since December 2020 and as President and CEO since April 2021. Mr. Mastrototaro has over 30 years of experience in the medical device industry, leading innovation and bringing new products to the market. Mr. Mastrototaro served as the Chief Operating Officer of Orthosensor, Inc. from 2017 to March 2021. Previously, Mr. Mastrototaro spent the majority of his career with Medtronic, PLC. and MiniMed, Inc., where he was instrumental in initiating and leading a series of firsts in the world of diabetes, including the ambulatory continuous glucose monitoring system, the sensor augmented insulin pump and the early generations of the artificial pancreas. Prior to joining Orthosensor, Mr. Mastrototaro was Medtronic's first VP of Informatics from 2013 to 2017, a role in which he helped develop a corporate strategy for the Movano Inc. e of data and analytics to improve healthcare delivery. During his tenure in Medtronic's Diabetes division, Mr. Mastrototaro held a number of positions, including CTO, VP of R&D and Business Development and Global VP of Clinical Research and Health Affairs. Mr. Mastrototaro started his career with Eli Lilly. He holds a B.A. in Mathematics and Physics from Holy Cross College and M.S. and Ph.D. in Biomedical Engineering from Duke University. Mr. Mastrototaro has authored over 50 peer reviewed manuscripts and holds over 60 US patents.
- Rubén Caballero
-
Ruben Caballero自2019年11月起担任公司董事。自2020年4月以来，卡瓦列罗一直担任微软混合现实部门设备与技术工程企业Vice President，负责监管混合现实、人工智能和其他特殊项目。卡瓦列罗曾于2005年至2019年4月担任苹果工程Vice President，在那里他是iPhone硬件设计团队的创始领导者之一，后来又将自己的职责扩展到iPad、Apple Watch、Macintosh和其他硬件产品。Caballero先生在苹果的高级职位为他提供了建立和扩大全球团队的机会，包括苹果所有产品/生态系统的无线设计和技术团队，包括iPhone，iPad，Mac，AirPods，HomePod和配件。任职Apple公司之前，他曾任职两家初创企业，在那里他曾领导设计无线网络音频组件和设备的创新产品和核心技术。自2019年8月起，卡瓦列罗先生担任ResonantInc.董事会成员Nasdaq:RESN，一家致力于改变移动手机和无线设备射频前端设计和交付方式的公司。Mr.Caballero在Cole Polytechnique de Montr&233；al获得电气工程学士学位，在New Mexico State University获得电气工程硕士学位，在Cole Polytechnique de Montr&233；al获得荣誉博士学位。
Rubén Caballero,has served as a director of the Company since November 2019. Since June 2024, Mr. Caballero has served as Chief Engineer and Strategy Officer at Humane Inc. From April 2020 until June 2024, Mr. Caballero served as Microsoft's Corporate Vice President of Devices & Technology Engineering for the Mixed Reality Division, where he oversaw Mixed Reality, AI and other special projects. Mr. Caballero served as a Vice President of Engineering at Apple from 2005 until April 2019, where he was one of the founding leaders of the iPhone hardware design team and later expanded his role to include iPad, Apple Watch, Macintosh, and other hardware products. Mr. Caballero's senior role at Apple provided him with the opportunity to build and scale global teams, including the Wireless Design and Technology team for all the products/ecosystems at Apple, including the iPhone, iPad, Macs, AirPods, HomePod, and accessories. Before Apple, Mr. Caballero worked at two start-ups, where he led efforts for designing innovative products and core technology for wireless networked audio components and devices. Since August 2019, Mr. Caballero has served as a member of the board of directors of Resonant Inc. (Nasdaq: RESN), a company that is working to transform the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices. Mr. Caballero received a Bachelor's degree in Electrical Engineering from cole Polytechnique de Montréal, a Master in Electrical Engineering from New Mexico State University and an Honorary Doctorate from cole Polytechnique de Montréal. - Ruben Caballero自2019年11月起担任公司董事。自2020年4月以来，卡瓦列罗一直担任微软混合现实部门设备与技术工程企业Vice President，负责监管混合现实、人工智能和其他特殊项目。卡瓦列罗曾于2005年至2019年4月担任苹果工程Vice President，在那里他是iPhone硬件设计团队的创始领导者之一，后来又将自己的职责扩展到iPad、Apple Watch、Macintosh和其他硬件产品。Caballero先生在苹果的高级职位为他提供了建立和扩大全球团队的机会，包括苹果所有产品/生态系统的无线设计和技术团队，包括iPhone，iPad，Mac，AirPods，HomePod和配件。任职Apple公司之前，他曾任职两家初创企业，在那里他曾领导设计无线网络音频组件和设备的创新产品和核心技术。自2019年8月起，卡瓦列罗先生担任ResonantInc.董事会成员Nasdaq:RESN，一家致力于改变移动手机和无线设备射频前端设计和交付方式的公司。Mr.Caballero在Cole Polytechnique de Montr&233；al获得电气工程学士学位，在New Mexico State University获得电气工程硕士学位，在Cole Polytechnique de Montr&233；al获得荣誉博士学位。
- Rubén Caballero,has served as a director of the Company since November 2019. Since June 2024, Mr. Caballero has served as Chief Engineer and Strategy Officer at Humane Inc. From April 2020 until June 2024, Mr. Caballero served as Microsoft's Corporate Vice President of Devices & Technology Engineering for the Mixed Reality Division, where he oversaw Mixed Reality, AI and other special projects. Mr. Caballero served as a Vice President of Engineering at Apple from 2005 until April 2019, where he was one of the founding leaders of the iPhone hardware design team and later expanded his role to include iPad, Apple Watch, Macintosh, and other hardware products. Mr. Caballero's senior role at Apple provided him with the opportunity to build and scale global teams, including the Wireless Design and Technology team for all the products/ecosystems at Apple, including the iPhone, iPad, Macs, AirPods, HomePod, and accessories. Before Apple, Mr. Caballero worked at two start-ups, where he led efforts for designing innovative products and core technology for wireless networked audio components and devices. Since August 2019, Mr. Caballero has served as a member of the board of directors of Resonant Inc. (Nasdaq: RESN), a company that is working to transform the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices. Mr. Caballero received a Bachelor's degree in Electrical Engineering from cole Polytechnique de Montréal, a Master in Electrical Engineering from New Mexico State University and an Honorary Doctorate from cole Polytechnique de Montréal.
- Brian Cullinan
-
Brian Cullinan自2020年8月起担任公司董事。Cullinan先生于1997年7月至2020年6月担任普华永道会计师事务所（PricewaterhouseCoopers LLP“；PWC”；）的合伙人。在普华永道（PwC）时，Cullinan先生担任高级关系和全球业务合作伙伴，负责众多普华永道财富500强客户。此外，他曾于2010年至2018年在普华永道会计师事务所（PwC&8217；S）美国合伙人和负责人董事会任职，包括2012年至2016年担任两届首席董事。Cullinan先生于2013年至2017年同时担任普华永道全球董事会成员，并于2011年至2017年担任西南地区管理合伙人。Cullinan先生在普华永道（PwC）的职业生涯中担任过许多其他领导职务，包括从2009年到2012年担任西部地区保证领导者，从2007年到2009年担任美国娱乐，媒体和通信保证领导者。他在康奈尔大学（Cornell University）获得文学学士学位，在东北大学（Northeastern University）获得财务会计理学硕士学位。
Brian Cullinan,has served as a director of the Company since August 2020. Mr. Cullinan was a partner at PricewaterhouseCoopers LLP ("PwC") from July 1997 through June 2020. While at PwC, Mr. Cullinan served as a Senior Relationship and Global Engagement Partner with responsibility for numerous PwC Fortune 500 clients. In addition, he served on PwC's U.S. Board of Partners & Principals from 2010 to 2018, including two terms as Lead Director from 2012 to 2016. Mr. Cullinan simultaneously served as a member of PwC's Global Board from 2013 to 2017 and as Managing Partner – Southwest Region from 2011 to 2017. Mr. Cullinan has served in numerous other leadership roles during his career at PwC, including West Region Assurance Leader from 2009 to 2012 and U.S. Entertainment, Media & Communications Assurance Leader from 2007 to 2009. He received a Bachelor of Arts from Cornell University and a Master of Science in Financial Accounting from Northeastern University. - Brian Cullinan自2020年8月起担任公司董事。Cullinan先生于1997年7月至2020年6月担任普华永道会计师事务所（PricewaterhouseCoopers LLP“；PWC”；）的合伙人。在普华永道（PwC）时，Cullinan先生担任高级关系和全球业务合作伙伴，负责众多普华永道财富500强客户。此外，他曾于2010年至2018年在普华永道会计师事务所（PwC&8217；S）美国合伙人和负责人董事会任职，包括2012年至2016年担任两届首席董事。Cullinan先生于2013年至2017年同时担任普华永道全球董事会成员，并于2011年至2017年担任西南地区管理合伙人。Cullinan先生在普华永道（PwC）的职业生涯中担任过许多其他领导职务，包括从2009年到2012年担任西部地区保证领导者，从2007年到2009年担任美国娱乐，媒体和通信保证领导者。他在康奈尔大学（Cornell University）获得文学学士学位，在东北大学（Northeastern University）获得财务会计理学硕士学位。
- Brian Cullinan,has served as a director of the Company since August 2020. Mr. Cullinan was a partner at PricewaterhouseCoopers LLP ("PwC") from July 1997 through June 2020. While at PwC, Mr. Cullinan served as a Senior Relationship and Global Engagement Partner with responsibility for numerous PwC Fortune 500 clients. In addition, he served on PwC's U.S. Board of Partners & Principals from 2010 to 2018, including two terms as Lead Director from 2012 to 2016. Mr. Cullinan simultaneously served as a member of PwC's Global Board from 2013 to 2017 and as Managing Partner – Southwest Region from 2011 to 2017. Mr. Cullinan has served in numerous other leadership roles during his career at PwC, including West Region Assurance Leader from 2009 to 2012 and U.S. Entertainment, Media & Communications Assurance Leader from 2007 to 2009. He received a Bachelor of Arts from Cornell University and a Master of Science in Financial Accounting from Northeastern University.
- Emily T. Fairbairn
-
Emily T.Fairbairn自2021年7月起担任我们的董事会成员。自2018年3月以来，Fairbairn女士一直担任MovanoInc.（一家专注于健康的技术公司）的董事会成员和主席。Fairbairn女士目前是Transcend Partners的负责人，从1999年到2018年，Fairbairn女士是Ascend Capital的联合创始人兼首席执行官，Ascend Capital是一家数十亿美元的对冲基金，专注于为养老金、捐赠基金和上市公司等机构客户管理资产。在创立Ascend Capital之前，Fairbairn女士为Merrill Lynch的高净值客户管理股票投资组合Fairbairn女士是一位活跃的慈善家，拥有支持教育、体育和医学研究的历史。她也是麻省理工学院沙盒创新基金的资助委员会成员，积极指导企业家。Fairbairn女士在加州州立理工大学波莫纳分校获得化学工程学士学位。
Emily T. Fairbairn has served as a member of our board of directors since July 2021. Since March 2018 Ms. Fairbairn has served a member and chair of the board of directors of Movano Inc., a health-focused technology company. Ms. Fairbairn is currently a principal of Transcend Partners and from 1999 to 2018 Ms. Fairbairn was the co-founder and CEO of Ascend Capital, a multi-billion hedge fund focused on managing assets for institutional clients such as pensions, endowments and public companies. Prior to founding Ascend Capital, Ms. Fairbairn managed equity portfolios for high net worth clients for Merrill Lynch Ms. Fairbairn is an active philanthropist with a history of supporting education, athletics, and medical research. She also serves on the funding board of MIT Sandbox Innovation Fund to actively mentor entrepreneurs. Ms. Fairbairn received her B.S. in Chemical Engineering from California State Polytechnic University Pomona. - Emily T.Fairbairn自2021年7月起担任我们的董事会成员。自2018年3月以来，Fairbairn女士一直担任MovanoInc.（一家专注于健康的技术公司）的董事会成员和主席。Fairbairn女士目前是Transcend Partners的负责人，从1999年到2018年，Fairbairn女士是Ascend Capital的联合创始人兼首席执行官，Ascend Capital是一家数十亿美元的对冲基金，专注于为养老金、捐赠基金和上市公司等机构客户管理资产。在创立Ascend Capital之前，Fairbairn女士为Merrill Lynch的高净值客户管理股票投资组合Fairbairn女士是一位活跃的慈善家，拥有支持教育、体育和医学研究的历史。她也是麻省理工学院沙盒创新基金的资助委员会成员，积极指导企业家。Fairbairn女士在加州州立理工大学波莫纳分校获得化学工程学士学位。
- Emily T. Fairbairn has served as a member of our board of directors since July 2021. Since March 2018 Ms. Fairbairn has served a member and chair of the board of directors of Movano Inc., a health-focused technology company. Ms. Fairbairn is currently a principal of Transcend Partners and from 1999 to 2018 Ms. Fairbairn was the co-founder and CEO of Ascend Capital, a multi-billion hedge fund focused on managing assets for institutional clients such as pensions, endowments and public companies. Prior to founding Ascend Capital, Ms. Fairbairn managed equity portfolios for high net worth clients for Merrill Lynch Ms. Fairbairn is an active philanthropist with a history of supporting education, athletics, and medical research. She also serves on the funding board of MIT Sandbox Innovation Fund to actively mentor entrepreneurs. Ms. Fairbairn received her B.S. in Chemical Engineering from California State Polytechnic University Pomona.
- Emily Wang Fairbairn
-
Emily Wang Fairbairn，自2018年3月起担任公司董事、董事会主席。Fairbairn女士曾于1999年至2018年担任数十亿美元对冲基金Ascend Capital的联合创始人兼首席执行官。该公司成立了多头/空头股票对冲基金业务，专注于为养老金、捐赠基金和上市公司等机构客户管理资产。从1987年到1997年，费尔贝恩女士为美林证券建立了为高净值客户管理股票投资组合的成功实践。从1985年到1987年，Fairbairn女士在百事可乐的Frito-Lay品牌担任工艺工程师和主管。费尔贝恩女士是一位活跃的慈善家，拥有支持教育、体育和医学研究的历史。自2021年7月起，Fairbairn女士担任IN8bio，Inc.（纳斯达克：INAB）的董事会成员。Fairbairn女士不仅在麻省理工学院沙盒创新基金的资金委员会任职，积极指导企业家，还担任CodeLogic，Inc.和Acelab Inc.的董事会成员和年轻企业的导师。Fairbairn女士在加州州立理工大学波莫纳分校获得化学工程学理学学士学位。
Emily Wang Fairbairn,has served as a director of the Company and Chair of the Board since March 2018. Ms. Fairbairn was co-founder and CEO of multi-billion-dollar hedge fund, Ascend Capital, from 1999 to 2018. The firm established a long/short equity hedge fund business focused on managing assets for institutional clients such as pensions, endowments and public companies. From 1987 to 1997, Ms. Fairbairn built a successful practice managing equity portfolios for high net worth clients for Merrill Lynch. From 1985 to 1987 Ms. Fairbairn worked as a process engineer and supervisor for Pepsi's Frito-Lay brand. Ms. Fairbairn is an active philanthropist with a hitory of supporting education, athletics, and medical research. Since July 2021, Ms. Fairbairn has served as a member of the board of directors of IN8bio, Inc. (Nasdaq: INAB). Ms. Fairbairn not only serves on the funding board of MIT Sandbox Innovation Fund to actively mentor entrepreneurs, but also serves as a board member and mentor to young enterprises for CodeLogic, Inc. and Acelab Inc. Ms. Fairbairn received her Bachelor of Science in chemical engineering from California State Polytechnic University Pomona. - Emily Wang Fairbairn，自2018年3月起担任公司董事、董事会主席。Fairbairn女士曾于1999年至2018年担任数十亿美元对冲基金Ascend Capital的联合创始人兼首席执行官。该公司成立了多头/空头股票对冲基金业务，专注于为养老金、捐赠基金和上市公司等机构客户管理资产。从1987年到1997年，费尔贝恩女士为美林证券建立了为高净值客户管理股票投资组合的成功实践。从1985年到1987年，Fairbairn女士在百事可乐的Frito-Lay品牌担任工艺工程师和主管。费尔贝恩女士是一位活跃的慈善家，拥有支持教育、体育和医学研究的历史。自2021年7月起，Fairbairn女士担任IN8bio，Inc.（纳斯达克：INAB）的董事会成员。Fairbairn女士不仅在麻省理工学院沙盒创新基金的资金委员会任职，积极指导企业家，还担任CodeLogic，Inc.和Acelab Inc.的董事会成员和年轻企业的导师。Fairbairn女士在加州州立理工大学波莫纳分校获得化学工程学理学学士学位。
- Emily Wang Fairbairn,has served as a director of the Company and Chair of the Board since March 2018. Ms. Fairbairn was co-founder and CEO of multi-billion-dollar hedge fund, Ascend Capital, from 1999 to 2018. The firm established a long/short equity hedge fund business focused on managing assets for institutional clients such as pensions, endowments and public companies. From 1987 to 1997, Ms. Fairbairn built a successful practice managing equity portfolios for high net worth clients for Merrill Lynch. From 1985 to 1987 Ms. Fairbairn worked as a process engineer and supervisor for Pepsi's Frito-Lay brand. Ms. Fairbairn is an active philanthropist with a hitory of supporting education, athletics, and medical research. Since July 2021, Ms. Fairbairn has served as a member of the board of directors of IN8bio, Inc. (Nasdaq: INAB). Ms. Fairbairn not only serves on the funding board of MIT Sandbox Innovation Fund to actively mentor entrepreneurs, but also serves as a board member and mentor to young enterprises for CodeLogic, Inc. and Acelab Inc. Ms. Fairbairn received her Bachelor of Science in chemical engineering from California State Polytechnic University Pomona.
- Shaheen Wirk
-
Shaheen Wirk是医疗保健专注投资的领导者，在医学、合作伙伴关系和研究领域拥有成功的记录。Wirk博士在公共和私人生命科学公司拥有超过20年的投资经验，是Palkon Capital Management的创始人兼首席投资官，这是一家与Julian Robertson和Tiger Management合作推出的医疗保健专用投资公司。此前，Wirk博士是Bridger Capital的高级分析师。他是咨询公司Blue Cotinga的创始人，是MercuryMD的早期雇员，该公司被Thomson Corp成功收购。他目前在多个董事会和协会任职，包括Tvardi Therapeutics和杜克大学医学院的医学校友理事会，这是医学校友协会的领导小组。Wirk博士在得克萨斯大学MD安德森癌症中心、通过美国国立卫生研究院Fogarty国际中心的拉宾医学中心和杜克大学医学中心完成了肿瘤学和创伤外科的研究培训项目。Wirk博士在杜克大学获得了医学博士、工商管理硕士和学士学位。
Shaheen Wirk,is a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research. With over 20 years of investment experience in public and private life science companies, Dr. Wirk is the founder and Chief Investment Officer of Palkon Capital Management, a healthcare dedicated investment firm launched in partnership with Julian Robertson and Tiger Management. Formerly, Dr. Wirk was a senior analyst at Bridger Capital. He is the founder of the advisory firm Blue Cotinga and was an early employee at MercuryMD, which was successfully acquired by the Thomson Corp. He currently serves on several boards and associations including Tvardi Therapeutics and the Duke University School of Medicine's Medical Alumni Council, the leadership group for the Medical Alumni Association. Dr. Wirk completed research training programs in oncology and trauma surgery at the University of Texas MD Anderson Cancer Center, Rabin Medical Center through the National Institutes of Health Fogarty International Center, and Duke University Medical Center. Dr. Wirk earned his M.D., M.B.A., and B.S. degrees from Duke University. - Shaheen Wirk是医疗保健专注投资的领导者，在医学、合作伙伴关系和研究领域拥有成功的记录。Wirk博士在公共和私人生命科学公司拥有超过20年的投资经验，是Palkon Capital Management的创始人兼首席投资官，这是一家与Julian Robertson和Tiger Management合作推出的医疗保健专用投资公司。此前，Wirk博士是Bridger Capital的高级分析师。他是咨询公司Blue Cotinga的创始人，是MercuryMD的早期雇员，该公司被Thomson Corp成功收购。他目前在多个董事会和协会任职，包括Tvardi Therapeutics和杜克大学医学院的医学校友理事会，这是医学校友协会的领导小组。Wirk博士在得克萨斯大学MD安德森癌症中心、通过美国国立卫生研究院Fogarty国际中心的拉宾医学中心和杜克大学医学中心完成了肿瘤学和创伤外科的研究培训项目。Wirk博士在杜克大学获得了医学博士、工商管理硕士和学士学位。
- Shaheen Wirk,is a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research. With over 20 years of investment experience in public and private life science companies, Dr. Wirk is the founder and Chief Investment Officer of Palkon Capital Management, a healthcare dedicated investment firm launched in partnership with Julian Robertson and Tiger Management. Formerly, Dr. Wirk was a senior analyst at Bridger Capital. He is the founder of the advisory firm Blue Cotinga and was an early employee at MercuryMD, which was successfully acquired by the Thomson Corp. He currently serves on several boards and associations including Tvardi Therapeutics and the Duke University School of Medicine's Medical Alumni Council, the leadership group for the Medical Alumni Association. Dr. Wirk completed research training programs in oncology and trauma surgery at the University of Texas MD Anderson Cancer Center, Rabin Medical Center through the National Institutes of Health Fogarty International Center, and Duke University Medical Center. Dr. Wirk earned his M.D., M.B.A., and B.S. degrees from Duke University.
- Michael Leabman
-
Michael Leabman，他创立了公司，并自2018年1月起担任董事会成员，自2021年4月1日起担任首席技术官。Leabman先生是一名连续企业家，对设想、发明和执行充满热情，他之前在omovano Inc.ly创立了fMovano Inc. 。其他无线领域的公司，并在电信/poMovano Inc.r的智能天线阵列方面拥有200多项专利。最近，Leabman先生创立了EnergoMovano Inc.。2012年10月至2018年5月担任其董事会成员，并于2013年10月至2018年1月担任其首席技术官。在EnergoMovano Inc.之前，Leabman先生创立并担任TruePath Wireless（宽带通信indMovano Inc.try的服务提供商和设备提供商）的总裁；创立并担任DataRunway Inc.（为航空公司提供宽带互联网的无线通信公司）的首席技术官。Leabman先生获得MassachMovano Inc.etts理工学院的电气工程学士学位和工程硕士学位。
Michael Leabman,founded the Company and has served as a member of its board of directors since January 2018, and as Chief Technology Officer since April 1st, 2021. As a serial entrepreneur with a passion for envisioning, inventing and executing, Mr. Leabman has previoMovano Inc.ly founded fMovano Inc. other companies in the wireless space and has more than 200 patents issued in smart antenna array for telecom/poMovano Inc.r. Most recently, Mr. Leabman founded EnergoMovano Inc. Corporation (Nasdaq: WATT), a wireless charging company, in October 2012, and served as a member of its board of directors from October 2012 until May 2018, and its Chief Technology Officer from October 2013 until January 2018. Prior to EnergoMovano Inc., Mr. Leabman founded and served as President of TruePath Wireless, a service provider and equipment provider in the broadband communications indMovano Inc.try and founded and served as CTO for DataRunway Inc., a wireless communication company providing broadband internet to airlines. Mr. Leabman received both his Bachelor of Science degree and Master of Engineering degree in electrical engineering from the MassachMovano Inc.etts Institute of Technology. - Michael Leabman，他创立了公司，并自2018年1月起担任董事会成员，自2021年4月1日起担任首席技术官。Leabman先生是一名连续企业家，对设想、发明和执行充满热情，他之前在omovano Inc.ly创立了fMovano Inc. 。其他无线领域的公司，并在电信/poMovano Inc.r的智能天线阵列方面拥有200多项专利。最近，Leabman先生创立了EnergoMovano Inc.。2012年10月至2018年5月担任其董事会成员，并于2013年10月至2018年1月担任其首席技术官。在EnergoMovano Inc.之前，Leabman先生创立并担任TruePath Wireless（宽带通信indMovano Inc.try的服务提供商和设备提供商）的总裁；创立并担任DataRunway Inc.（为航空公司提供宽带互联网的无线通信公司）的首席技术官。Leabman先生获得MassachMovano Inc.etts理工学院的电气工程学士学位和工程硕士学位。
- Michael Leabman,founded the Company and has served as a member of its board of directors since January 2018, and as Chief Technology Officer since April 1st, 2021. As a serial entrepreneur with a passion for envisioning, inventing and executing, Mr. Leabman has previoMovano Inc.ly founded fMovano Inc. other companies in the wireless space and has more than 200 patents issued in smart antenna array for telecom/poMovano Inc.r. Most recently, Mr. Leabman founded EnergoMovano Inc. Corporation (Nasdaq: WATT), a wireless charging company, in October 2012, and served as a member of its board of directors from October 2012 until May 2018, and its Chief Technology Officer from October 2013 until January 2018. Prior to EnergoMovano Inc., Mr. Leabman founded and served as President of TruePath Wireless, a service provider and equipment provider in the broadband communications indMovano Inc.try and founded and served as CTO for DataRunway Inc., a wireless communication company providing broadband internet to airlines. Mr. Leabman received both his Bachelor of Science degree and Master of Engineering degree in electrical engineering from the MassachMovano Inc.etts Institute of Technology.
高管简历
中英对照 | 中文 | 英文- John Mastrototaro
John Mastrototaro自2020年12月起担任公司董事，并同意不迟于2021年4月1日成为我们的总裁兼首席执行官。Mastrototaro先生在医疗器械行业拥有超过30年的经验，领导创新并将新产品推向市场。Mastrototaro先生自2017年以来一直担任Orthosensor，Inc.的首席运营官。此前，Mastrototaro先生在Medtronic，plc.和Minimed，Inc.度过了职业生涯的大部分时间，在那里他在发起和领导糖尿病世界的一系列第一方面发挥了重要作用，包括动态连续血糖监测系统，该传感器增强了胰岛素泵和早期人工胰腺。在加入Orthosensor之前，Mastrototaro先生于2013年至2017年担任美敦力（Medtronic&8217；）的首位信息学副总裁，他在该职位上帮助制定了一项利用数据和分析改善梦百合交付的企业战略。在Medtronic&8217；s Diabetes Division任职期间，Mastrototaro先生担任多个职位，包括CTO，研发与业务发展副总裁和临床研究与健康事务全球副总裁。Mastrototaro先生的职业生涯始于礼来公司（Eli Lilly）。他持有Holy Cross College的数学和物理学士学位，以及Duke University的生物医学工程硕士和博士学位。Mastrototaro先生撰写了超过50篇同行评议的手稿，并拥有超过60项美国专利。
John Mastrototaro,has served as a director of the Company since December 2020 and as President and CEO since April 2021. Mr. Mastrototaro has over 30 years of experience in the medical device industry, leading innovation and bringing new products to the market. Mr. Mastrototaro served as the Chief Operating Officer of Orthosensor, Inc. from 2017 to March 2021. Previously, Mr. Mastrototaro spent the majority of his career with Medtronic, PLC. and MiniMed, Inc., where he was instrumental in initiating and leading a series of firsts in the world of diabetes, including the ambulatory continuous glucose monitoring system, the sensor augmented insulin pump and the early generations of the artificial pancreas. Prior to joining Orthosensor, Mr. Mastrototaro was Medtronic's first VP of Informatics from 2013 to 2017, a role in which he helped develop a corporate strategy for the Movano Inc. e of data and analytics to improve healthcare delivery. During his tenure in Medtronic's Diabetes division, Mr. Mastrototaro held a number of positions, including CTO, VP of R&D and Business Development and Global VP of Clinical Research and Health Affairs. Mr. Mastrototaro started his career with Eli Lilly. He holds a B.A. in Mathematics and Physics from Holy Cross College and M.S. and Ph.D. in Biomedical Engineering from Duke University. Mr. Mastrototaro has authored over 50 peer reviewed manuscripts and holds over 60 US patents.- John Mastrototaro自2020年12月起担任公司董事，并同意不迟于2021年4月1日成为我们的总裁兼首席执行官。Mastrototaro先生在医疗器械行业拥有超过30年的经验，领导创新并将新产品推向市场。Mastrototaro先生自2017年以来一直担任Orthosensor，Inc.的首席运营官。此前，Mastrototaro先生在Medtronic，plc.和Minimed，Inc.度过了职业生涯的大部分时间，在那里他在发起和领导糖尿病世界的一系列第一方面发挥了重要作用，包括动态连续血糖监测系统，该传感器增强了胰岛素泵和早期人工胰腺。在加入Orthosensor之前，Mastrototaro先生于2013年至2017年担任美敦力（Medtronic&8217；）的首位信息学副总裁，他在该职位上帮助制定了一项利用数据和分析改善梦百合交付的企业战略。在Medtronic&8217；s Diabetes Division任职期间，Mastrototaro先生担任多个职位，包括CTO，研发与业务发展副总裁和临床研究与健康事务全球副总裁。Mastrototaro先生的职业生涯始于礼来公司（Eli Lilly）。他持有Holy Cross College的数学和物理学士学位，以及Duke University的生物医学工程硕士和博士学位。Mastrototaro先生撰写了超过50篇同行评议的手稿，并拥有超过60项美国专利。
- John Mastrototaro,has served as a director of the Company since December 2020 and as President and CEO since April 2021. Mr. Mastrototaro has over 30 years of experience in the medical device industry, leading innovation and bringing new products to the market. Mr. Mastrototaro served as the Chief Operating Officer of Orthosensor, Inc. from 2017 to March 2021. Previously, Mr. Mastrototaro spent the majority of his career with Medtronic, PLC. and MiniMed, Inc., where he was instrumental in initiating and leading a series of firsts in the world of diabetes, including the ambulatory continuous glucose monitoring system, the sensor augmented insulin pump and the early generations of the artificial pancreas. Prior to joining Orthosensor, Mr. Mastrototaro was Medtronic's first VP of Informatics from 2013 to 2017, a role in which he helped develop a corporate strategy for the Movano Inc. e of data and analytics to improve healthcare delivery. During his tenure in Medtronic's Diabetes division, Mr. Mastrototaro held a number of positions, including CTO, VP of R&D and Business Development and Global VP of Clinical Research and Health Affairs. Mr. Mastrototaro started his career with Eli Lilly. He holds a B.A. in Mathematics and Physics from Holy Cross College and M.S. and Ph.D. in Biomedical Engineering from Duke University. Mr. Mastrototaro has authored over 50 peer reviewed manuscripts and holds over 60 US patents.
- Jeremy Cogan
Jeremy Cogan自2019年5月起担任公司首席财务官。从2007年7月至2018年12月，Cogan先生管理Ascend Capital的休闲与媒体投资组合，Ascend Capital是一家位于旧金山湾区的数十亿美元的多头/空头股票对冲基金。在Ascend，他也是公司执行委员会的成员。Cogan从1995年1月到2007年5月担任Banc of America Securities LLC及其前身股票研究团队成员。在Banc of America Securities任职的大部分时间里，Cogan先生是首席和高级股票研究分析师，负责博彩和住宿部门。Cogan先生在宾夕法尼亚大学（University of Pennsylvania）获得传播学文学学士学位，并自2000年9月起担任特许金融分析师（CFA）特许持有人。
Jeremy Cogan,has served as the Company's Chief Financial Officer since May 2019.From July 2007 to December 2018, Mr. Cogan managed the Leisure & Media portfolio at Ascend Capital, a multi-billion-dollar, long/short equity hedge fund, based in the San Francisco Bay Area. At Ascend, he was also a member of the firm's Executive Committee. From January 1995 to May 2007, Mr. Cogan was a member of the equity research team at Banc of America Securities LLC (and its predecessors). For the majority of his tenure at Banc of America Securities, Mr. Cogan was a Principal and Senior Equity Research Analyst, responsible for the Gaming and Lodging sectors. Mr. Cogan received a Bachelor of Arts degree in Communications from the University of Pennsylvania.- Jeremy Cogan自2019年5月起担任公司首席财务官。从2007年7月至2018年12月，Cogan先生管理Ascend Capital的休闲与媒体投资组合，Ascend Capital是一家位于旧金山湾区的数十亿美元的多头/空头股票对冲基金。在Ascend，他也是公司执行委员会的成员。Cogan从1995年1月到2007年5月担任Banc of America Securities LLC及其前身股票研究团队成员。在Banc of America Securities任职的大部分时间里，Cogan先生是首席和高级股票研究分析师，负责博彩和住宿部门。Cogan先生在宾夕法尼亚大学（University of Pennsylvania）获得传播学文学学士学位，并自2000年9月起担任特许金融分析师（CFA）特许持有人。
- Jeremy Cogan,has served as the Company's Chief Financial Officer since May 2019.From July 2007 to December 2018, Mr. Cogan managed the Leisure & Media portfolio at Ascend Capital, a multi-billion-dollar, long/short equity hedge fund, based in the San Francisco Bay Area. At Ascend, he was also a member of the firm's Executive Committee. From January 1995 to May 2007, Mr. Cogan was a member of the equity research team at Banc of America Securities LLC (and its predecessors). For the majority of his tenure at Banc of America Securities, Mr. Cogan was a Principal and Senior Equity Research Analyst, responsible for the Gaming and Lodging sectors. Mr. Cogan received a Bachelor of Arts degree in Communications from the University of Pennsylvania.
- Michael Leabman
Michael Leabman，他创立了公司，并自2018年1月起担任董事会成员，自2021年4月1日起担任首席技术官。Leabman先生是一名连续企业家，对设想、发明和执行充满热情，他之前在omovano Inc.ly创立了fMovano Inc. 。其他无线领域的公司，并在电信/poMovano Inc.r的智能天线阵列方面拥有200多项专利。最近，Leabman先生创立了EnergoMovano Inc.。2012年10月至2018年5月担任其董事会成员，并于2013年10月至2018年1月担任其首席技术官。在EnergoMovano Inc.之前，Leabman先生创立并担任TruePath Wireless（宽带通信indMovano Inc.try的服务提供商和设备提供商）的总裁；创立并担任DataRunway Inc.（为航空公司提供宽带互联网的无线通信公司）的首席技术官。Leabman先生获得MassachMovano Inc.etts理工学院的电气工程学士学位和工程硕士学位。
Michael Leabman,founded the Company and has served as a member of its board of directors since January 2018, and as Chief Technology Officer since April 1st, 2021. As a serial entrepreneur with a passion for envisioning, inventing and executing, Mr. Leabman has previoMovano Inc.ly founded fMovano Inc. other companies in the wireless space and has more than 200 patents issued in smart antenna array for telecom/poMovano Inc.r. Most recently, Mr. Leabman founded EnergoMovano Inc. Corporation (Nasdaq: WATT), a wireless charging company, in October 2012, and served as a member of its board of directors from October 2012 until May 2018, and its Chief Technology Officer from October 2013 until January 2018. Prior to EnergoMovano Inc., Mr. Leabman founded and served as President of TruePath Wireless, a service provider and equipment provider in the broadband communications indMovano Inc.try and founded and served as CTO for DataRunway Inc., a wireless communication company providing broadband internet to airlines. Mr. Leabman received both his Bachelor of Science degree and Master of Engineering degree in electrical engineering from the MassachMovano Inc.etts Institute of Technology.- Michael Leabman，他创立了公司，并自2018年1月起担任董事会成员，自2021年4月1日起担任首席技术官。Leabman先生是一名连续企业家，对设想、发明和执行充满热情，他之前在omovano Inc.ly创立了fMovano Inc. 。其他无线领域的公司，并在电信/poMovano Inc.r的智能天线阵列方面拥有200多项专利。最近，Leabman先生创立了EnergoMovano Inc.。2012年10月至2018年5月担任其董事会成员，并于2013年10月至2018年1月担任其首席技术官。在EnergoMovano Inc.之前，Leabman先生创立并担任TruePath Wireless（宽带通信indMovano Inc.try的服务提供商和设备提供商）的总裁；创立并担任DataRunway Inc.（为航空公司提供宽带互联网的无线通信公司）的首席技术官。Leabman先生获得MassachMovano Inc.etts理工学院的电气工程学士学位和工程硕士学位。
- Michael Leabman,founded the Company and has served as a member of its board of directors since January 2018, and as Chief Technology Officer since April 1st, 2021. As a serial entrepreneur with a passion for envisioning, inventing and executing, Mr. Leabman has previoMovano Inc.ly founded fMovano Inc. other companies in the wireless space and has more than 200 patents issued in smart antenna array for telecom/poMovano Inc.r. Most recently, Mr. Leabman founded EnergoMovano Inc. Corporation (Nasdaq: WATT), a wireless charging company, in October 2012, and served as a member of its board of directors from October 2012 until May 2018, and its Chief Technology Officer from October 2013 until January 2018. Prior to EnergoMovano Inc., Mr. Leabman founded and served as President of TruePath Wireless, a service provider and equipment provider in the broadband communications indMovano Inc.try and founded and served as CTO for DataRunway Inc., a wireless communication company providing broadband internet to airlines. Mr. Leabman received both his Bachelor of Science degree and Master of Engineering degree in electrical engineering from the MassachMovano Inc.etts Institute of Technology.